ANUHPHR vs VAISHALI: Stock Comparison

Anuh Pharma Limited vs Vaishali Pharma Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Anuh Pharma Limited is the larger company by market capitalisation. Anuh Pharma Limited shows a higher ROE, a higher dividend yield and lower leverage, while Vaishali Pharma Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anuh Pharma Limited and Vaishali Pharma Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ANUHPHR is more favourable on 9 of 11 scored metrics and VAISHALI on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ANUHPHR is the larger company
₹793 Cr vs ₹102 Cr
EPS
ANUHPHR has higher earnings per share
₹4.1 vs ₹0.33
Dividend Yield
ANUHPHR has a higher dividend yield
1.87% vs 0%
Revenue Growth (TTM YoY)
VAISHALI has faster revenue growth
18.35% vs 2%
EPS Growth (TTM YoY)
ANUHPHR has faster EPS growth
-6% vs -76.71%
Qtr Sales Growth
VAISHALI has stronger quarterly sales growth
31.4% vs 2.01%
Qtr Profit Growth
ANUHPHR has stronger quarterly profit growth
-6.26% vs -24.7%
ROE
ANUHPHR has a higher ROE
12.1% vs 6.03%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANUHPHRVAISHALI
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricANUHPHRVAISHALI
Live Price₹79.07₹8.29
Day Change-0.48%-5.8%
Volume17,3424.19 L
52-Week High₹101.7₹13.1
52-Week Low₹67₹4.75
Distance from 52W High-22.25%-36.72%

Valuation

MetricANUHPHRVAISHALI
Market Cap₹793 Cr₹102 Cr
P/E Ratio19.37x
P/B Ratio2.26x
EPS₹4.1₹0.33
Book Value₹35.28₹4.98
Dividend Yield1.87%0%

Growth

MetricANUHPHRVAISHALI
Revenue Growth (TTM YoY)2%18.35%
EPS Growth (TTM YoY)-6%-76.71%
Qtr Sales Growth2.01%31.4%
Qtr Profit Growth-6.26%-24.7%

Profitability & Leverage

MetricANUHPHRVAISHALI
ROE12.1%6.03%
ROCE15.9%4.93%
Net Margin5.32%3.83%
Operating Margin8%6.76%
Debt to Equity0x0.27x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricANUHPHRVAISHALI
Promoter Holding71.78% 0.02 pp31.61%
FII Holding0.05% 0.05 pp0%
DII Holding0%0%
Public Holding28.16% 0.02 pp68.39%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anuh Pharma Limited and Vaishali Pharma Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.